While EGR1 is destabilized by PAX-FOXO1 in ARMS, we show that enhanced expression can overcome this effect and we are currently investigating other regulatory mechanisms that inhibit the expression of EGR1 in RMS. The gene discussed is FOXO1; the disease is alveolar rhabdomyosarcoma.